Goeller Anja, Pogarell Tobias, May Matthias Stefan, Uder Michael, Dankerl Peter
Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.
Diagnostics (Basel). 2021 Oct 4;11(10):1835. doi: 10.3390/diagnostics11101835.
To evaluate patients' radiation exposure undergoing CT-guided joint injection in preparation of MR-arthrography. We developed a novel ultra-low-dose protocol utilizing tin-filtration, performed it in 60 patients and compared the radiation exposure (DLP) and success rate to conventional protocol (26 cases) and low-dose protocol (37 cases). We evaluated 123 patients' radiation exposure undergoing CT-guided joint injection from 16 January-21 March. A total of 55 patients received CT-guided joint injections with various other examination protocols and were excluded from further investigation. In total, 56 patients received shoulder injection and 67 received hip injection with consecutive MR arthrography. The ultra-low-dose protocol was performed in 60 patients, the low-dose protocol in 37 patients and the conventional protocol in 26 patients. We compared the dose of the interventional scans for each protocol (DLP) and then evaluated success rate with MR-arthrography images as gold standard of intraarticular or extracapsular contrast injection. There were significant differences when comparing the DLP of the ultra-low-dose protocol (DLP 1.1 ± 0.39; < 0.01) to the low dose protocol (DLP 5.3 ± 3.24; < 0.01) as well as against the conventional protocol (DLP 22.9 ± 8.66; < 0.01). The ultra-low-dose protocol exposed the patients to an average effective dose of 0.016 millisievert and resulted in a successful joint injection in all 60 patients. The low dose protocol as well as the conventional protocol were also successful in all patients. The presented ultra-low-dose CT-guided joint injection protocol for the preparation of MR-arthrography demonstrated to reduce patients' radiation dose in a way that it was less than the equivalent of the natural radiation exposure in Germany over 3 days-and thereby, negligible to the patient.
为评估在进行磁共振关节造影术前接受CT引导下关节注射的患者的辐射暴露情况。我们开发了一种利用锡过滤的新型超低剂量方案,对60例患者实施了该方案,并将辐射暴露(剂量长度乘积,DLP)和成功率与传统方案(26例)及低剂量方案(37例)进行比较。我们评估了1月16日至3月21日期间123例接受CT引导下关节注射的患者的辐射暴露情况。共有55例患者接受了采用各种其他检查方案的CT引导下关节注射,并被排除在进一步研究之外。总计56例患者接受了肩部注射,67例接受了髋部注射并随后进行磁共振关节造影。60例患者采用了超低剂量方案,37例患者采用了低剂量方案,26例患者采用了传统方案。我们比较了各方案介入扫描的剂量(DLP),然后以磁共振关节造影图像作为关节内或关节囊外造影剂注射的金标准来评估成功率。将超低剂量方案的DLP(DLP 1.1±0.39;<0.01)与低剂量方案(DLP 5.3±3.24;<0.01)以及传统方案(DLP 22.9±8.66;<0.01)进行比较时,存在显著差异。超低剂量方案使患者平均有效剂量达到0.016毫希沃特,并且所有60例患者的关节注射均成功。低剂量方案和传统方案的所有患者也均成功。所提出的用于磁共振关节造影术前准备的CT引导下超低剂量关节注射方案显示,可降低患者的辐射剂量,其降低程度小于德国3天的自然辐射暴露量,因此对患者而言可忽略不计。